Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1985-01-18
1987-09-08
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Lymphokine
424 85, 424 86, 424 87, 424 89, 424 90, 424 92, 424 95, A61K 3900, A61K 4505, A61K 3940
Patent
active
046923322
ABSTRACT:
A method and composition for treating malignant neoplasia and acquired immune deficiency syndrome by once daily administration of a substance (such as human chorionic gonadotropin) characteristic of the tumor or acquired immune deficiency syndrome-afflicted cell in an amount less than the lowest amount necessary to provoke a humoral immune response, as exemplified by the existence of a negative wheal upon subcutaneous administration.
REFERENCES:
patent: 2310937 (1943-02-01), Connell
patent: 3269913 (1966-08-01), Devlin et al.
patent: 3567822 (1971-03-01), Sarbach
patent: 3855197 (1974-12-01), Hirsch
patent: 4285930 (1981-08-01), Likhite
patent: 4311688 (1982-01-01), Burchiel
patent: 4323546 (1982-04-01), Crockford
patent: 4410510 (1983-10-01), Livingston
patent: 4460575 (1984-07-01), d'Hinterland
Knecht C.A. 92 #88377m (1980).
Papa Demetrou C.A. 96 #15389q (1982).
Miyakoshi C.A. 96 #67127x (1982)
Cooper C.A. 100 #84075x 1984.
Cohen C.A. 101 #65664t (1984).
Langone C.A. 101 #88606g (1984).
Chugai C.A. 101 #235588r (1984).
Ray C.A. 102 #39594n (1985)
Melmed C.A. 99 #689a (1983).
Oeltmann C.A. 104 #46926a (1986).
Hlavayova C.A. 100 #96263v (1984).
Liu C.A. 101 #70689j (1984).
Liu C.A. 101 #228353g (1984).
Baynt C.A. 100 #83936s (1984).
Mitsui C.A. 101 #17331k (1984).
Langvad C.A. 102 #72519y (1985).
Harper C.A. 103 #47877b (1985).
Derwent 89190 of JPN. 55139-322 10.31.80 Fujizoki
LandOfFree
Immunotherapeutic methods and compositions employing antigens ch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic methods and compositions employing antigens ch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic methods and compositions employing antigens ch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2157501